| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |